Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bon Natural Life Limited (BON) vs Northern Technologies International Corporation (NTIC)

Bon Natural Life Limited and Northern Technologies International Corporation are both Specialty Chemicals companies. Northern Technologies International Corporation is the larger, with a market value of $74.6M against $9.9M — 7.5× the size. Northern Technologies International Corporation has negative trailing earnings, so its P/E is not meaningful; Bon Natural Life Limited trades at 1.0×. Bon Natural Life Limited grew revenue faster over the last twelve months: 53.3% against 7.70%. Bon Natural Life Limited has the higher net margin (18.4% vs −1.26%) and the lower return on invested capital (0.00% vs 2.03%). Across the 16 metrics below, Bon Natural Life Limited leads on 10 and Northern Technologies International Corporation on 6.

Valuation

Metric BON NTIC Specialty Chemicals median
P/E 0.95 n/m 24.83
P/S n/m 0.81 1.46
P/B n/m 0.96 1.76
Price to free cash flow n/m n/m 19.84
EV/EBITDA n/m 17.33 13.18
EV/Sales (0.07) 0.89 1.84
Earnings yield 105.00% (1.54%) 2.11%
Free cash flow yield 0.00% (5.31%) 2.29%

Profitability

Metric BON NTIC Specialty Chemicals median
Gross margin 30.90% 35.76% 29.23%
Operating margin 0.00% 3.01% 3.63%
Net margin 18.39% (1.26%) 2.89%
Free cash flow margin 0.00% (4.28%) 3.78%
Return on equity 0.00% (1.51%) 3.62%
Return on assets 0.00% (1.12%) 0.35%
Return on invested capital 0.00% 2.03% 2.75%

Growth

Metric BON NTIC Specialty Chemicals median
Revenue growth (TTM) 53.31% 7.70% 4.51%
EPS growth (last fiscal year) (116.94%) (100.00%) —
Revenue growth, 5-year CAGR 0.49% 12.07% 6.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BON NTIC Specialty Chemicals median
Debt to equity 0.03 0.20 0.54
Current ratio 1.74 1.72 1.94
Net debt to EBITDA 12.88 1.25 2.03

Dividend

Metric BON NTIC Specialty Chemicals median
Dividend yield — 2.06% 1.69%
Payout ratio 0.00 0.76 0.25

Size

Metric BON NTIC Specialty Chemicals median
Market cap 9.88m 74.55m 2.43b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack